Several Methods for Early Diagnosis of Alzheimer’s Disease Developed

ScienceDaily (June 15, 2011) — PredictAD is an EU-funded research project that develops objective and efficient methods for enabling earlier diagnosis of Alzheimer’s disease. Diagnosis requires a holistic view of the patient combining information from several sources, such as, clinical tests, imaging and blood samples.

“The aim of the PredictAD project is to develop an objective indicator to diagnose Alzheimer’s disease at the earliest stage possible. Current diagnostic guidelines emphasise the importance of various biomarkers in diagnostics. We have developed novel approaches to extract biomarkers from imaging data, electrophysiological data and blood samples, and a unique and clinically useful software tool for integrating all these heterogeneous measurements.” says the Scientific Coordinator of the project, Dr Jyrki Lötjönen from VTT Technical Research Centre of Finland.

Magnetic resonance imaging for identifying atrophy

 

Atrophy in the mediotemporal lobe is a well-known hallmark of Alzheimer’s disease. Magnetic resonance imaging is an excellent tool for measuring this tissue loss. In current clinical practice, images are interpreted mostly only by visual inspection but there is a great need for objective measurements.

PredictAD has developed several methods to meet this need. “We have managed to develop efficient tools for measuring the size of the hippocampus, the atrophy rate of the hippocampus, and two modern approaches based on comparing patient data with previously diagnosed cases available in large databases.” says the leader of the imaging biomarkers work-package, professor Daniel Rueckert from Imperial College London. Positron emission tomography (PET) imaging is another imaging technology studied in the project. A novel tracer developed recently especially for diagnostics of Alzheimer’s disease provides promises for very early diagnosis of the disease.

Detecting changes in the electrophysiology of the brain

 

Alzheimer’s disease is known to affect the electromagnetic activity of the brain. In PredictAD, we have studied the performance of a novel technology, transcranial magnetic stimulation (TMS) combined with electroencephalographic (EEG) measures in detecting the disease. The strength of TMS/EEG is that it allows direct and non-invasive perturbation of the human cerebral cortex without requiring the subject’s collaboration. Our study has shown significant changes in Alzheimer’s patients compared with healthy aging people.

Non-invasive techniques to find biomarkers of the disease

 

Molecular level biomarkers are currently under extensive studies in Alzheimer’s research. Many biomarkers, such as tau proteins and b-amyloid 42, measured from the cerebrospinal fluid (CSF), the liquid surrounding the cerebral cortex, have been found to be strongly related with the disease. One major challenge of these biomarkers is that taking samples from CSF is an invasive measurement limiting their usability in early diagnostics. Blood samples would be an excellent source for detecting Alzheimer’s disease as blood sampling is not considered an invasive technique. PredictAD has studied the role of metabolomic and protein compounds in Alzheimer’s disease from blood samples. The preliminary results reveal several promising compounds.

Methodology for measuring the state of the patient

 

Currently, clinicians make the final diagnosis by combining heterogeneous measurements with information from interviews of the patient and relatives. This process involves subjective reasoning and requires strong expertise from the clinicians. Modern hospitals have huge data reserves containing hidden information that could be utilised in diagnostics by systematic mathematical modelling.

PredictAD has designed a totally novel approach for measuring objectively the state of the patient. This decision support system, developed in close collaboration with clinicians, compares patient measurements with measurements of other patients in large databases and provides at the end an index and graphical representation reflecting the state of the patient. “The PredictAD tool provides a new option to support decision making,” says Prof. Hilkka Soininen from the University of Eastern Finland, leading the clinical validation of the project.

Possibilities for significant savings in health costs

 

Prof. Gunhild Waldemar from Copenhagen University Hospital, Rigshospitalet emphasises the importance of the Alzheimer’s disease research: “Successful, early diagnostics combined with the novel drugs under development and early psychosocial care may delay the institutionalisation of patients, reducing suffering and the costs to the society. It has been calculated that delaying the onset of the disease by five years would halve all costs of Alzheimer’s disease and delaying onset and progression by only one year would reduce the number of Alzheimer’s cases by about 10%.”

Read more http://www.sciencedaily.com/releases/2011/06/110615062000.htm

Share

Posted: June 16th, 2011 under Uncategorized.

RSS Medical Imaging News

  • Novel ultrasound technology to screen for heart conditions developed by engineers October 29, 2014
    Engineers have determined, for the first time, the impact of a ring-shaped vortex on transporting blood flow in normal and abnormal ventricles within the human heart, and have developed a novel ultrasound technology that makes screening cheaper and much easier, making it possible to reach a large number of people and even infants.
  • Brain abnormalities found in chronic fatigue patients October 29, 2014
    An imaging study has found distinct differences between the brains of patients with chronic fatigue syndrome and those of healthy people.
  • New technology shows promise for delivery of therapeutics to the brain October 28, 2014
    Researchers have created “a tool for blood-barrier-brain disruption that uses bursts of sub-microsecond bipolar pulses to enhance the transfer of large molecules to the brain.” According to the authors, the current medical use of chemotherapy to treat brain cancer can be inefficient because of the blood-brain-barrier that impedes the delivery of drugs out of […]
  • Tomosynthesis improves cancer detection in women with dense breast tissue October 28, 2014
    As of October 2014, 19 states have enacted laws requiring women to be directly informed if they have dense breasts and would benefit from supplemental screening. However, the recommended type of supplemental screening for women with dense breasts remains unclear. With 15 additional states considering similar laws and federal legislation introduced, physician […]
  • Preventative action prior to brain surgery: Ultra-high-field MRI reveals language centers in brain in much more detail October 28, 2014
    It is now possible, for the first time, to demonstrate that the areas of the brain that are important for understanding language can be pinpointed much more accurately using ultra-high-field MRI (7 Tesla) than with conventional clinical MRI scanners. This research helps to protect these areas more effectively during brain surgery and avoid accidentally damag […]
  • Ultrasound guides tongue to pronounce 'R' sounds October 27, 2014
    Using ultrasound technology to visualize the tongue’s shape and movement can help children with difficulty pronouncing “r” sounds, according to a small study. The ultrasound intervention was effective when individuals were allowed to make different shapes with their tongue in order to produce the "r" sound, rather than being instructed to make a sp […]
  • Brain development in utero observed by researchers October 27, 2014
    New investigation methods using functional magnetic resonance tomography (fMRT) offer insights into fetal brain development. These "in vivo" observations will uncover different stages of the brain's development. A research group has observed that parts of the brain that are later responsible for sight are already active at this stage.
  • New hope for potential prostate cancer patients October 25, 2014
    It has been more than 30 years since the last major advancement in prostate cancer screening technology, and the latest advancement is now available in the United States. It is estimated that 2014 will see more than 240,000 new cases of prostate cancer, and more than 29,000 deaths from the disease.
  • Breast cancer tumor response to neoadjuvant chemotherapy measured October 23, 2014
    It may be possible to use Diffuse Optical Spectroscopic Tomographic imaging (DOST) to predict which patients will best respond to chemotherapy used to shrink breast cancer tumors before surgery, a study shows.
  • New window of opportunity to prevent cardiovascular, diseases October 23, 2014
    Future prevention and treatment strategies for vascular diseases may lie in the evaluation of early brain imaging tests long before heart attacks or strokes occur, according to a systematic review conducted by a team of cardiologists, neuroscientists, and psychiatrists.

News Items

Links